Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

VERNALIS PLC (VER)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vernalis plc
Researches and develops pharmaceutical products

Vernalis Plc is a commercial stage pharmaceutical company.

Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market; Moxatag, a once-a-day formulation of the antibiotic and amoxicillin; and frovatriptan, used for the acute treatment of migraine.

Vernalis also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market.

The company was founded by Keith G. McCullagh in 1986 and is headquartered in Winnersh, United Kingdom.

Number of employees : 115 persons.
Sales per Businesses
20162017Delta
GBP (in Million)%GBP (in Million)%
Research & Development8.0466.8%14.4069.3% +79.12%
Commercial3.9933.2%6.3930.7% +59.96%
Sales per Regions
20162017Delta
GBP (in Million)%GBP (in Million)%
Rest of Europe8.1367.6%14.2468.5% +75.05%
Rest of the World2.7322.7%1.989.5% -27.72%
North America1.169.7%4.5822% +293.89%
United Kingdom0.0050%---
Managers
NameAgeSinceTitle
Ian Garland532008Chief Executive Officer & Executive Director
Sandford Sommer-2016President & Chief Operating Officer
Peter John Fellner, PhD742003Non-Executive Chairman
David MacKney502009Chief Financial Officer & Executive Director
Mike Wood-2004Research Director
Pascal Borderies, MD-2014Senior Vice President-Medical Affairs
Carol C. Ferguson712003Senior Independent Non-Executive Director
Nigel Sheail532011Independent Non-Executive Director
Ian David Gilham, PhD582015Independent Non-Executive Director
Lisa Amster Schoenberg, MBA522015Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 526,819,624 520,268,687 98.8% 0 0.0% 98.8%
Shareholders
NameEquities%
Invesco Asset Management Ltd. 194,417,167 36.9%
Woodford Investment Management Ltd. 157,876,138 30.0%
GAM London Ltd. 36,770,756 6.98%
Legal & General Investment Management Ltd. 28,844,930 5.48%
GAM International Management Ltd. 23,235,104 4.41%
Aviva Investors Global Services Ltd. 21,093,530 4.00%
Rothschild Wealth Management (UK) Ltd. 12,129,164 2.30%
Hargreaves Lansdown Asset Management Ltd. 6,452,000 1.22%
Medical Strategy GmbH 6,368,929 1.21%
EdenTree Investment Management Ltd. 3,159,729 0.60%
Company contact information
Vernalis Plc
100 Berkshire Place
Wharfedale Road
Winnersh, Berkshire RG41 5RD

Phone : +44.118.938.0000
Fax : +44.118.938.0001
Web : www.vernalis.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
VERNALIS PLC-58.19%27
CELLTRION, INC.--.--%31 274
IQVIA HOLDINGS INC-0.64%20 671
LONZA GROUP-6.84%18 497
NEKTAR THERAPEUTICS44.36%14 892
INCYTE CORPORATION-27.75%14 841
ALNYLAM PHARMACEUTICALS, INC.-23.27%9 787
SEATTLE GENETICS, INC.-7.14%8 033
SAGE THERAPEUTICS INC-10.14%7 894
QIAGEN6.08%7 636
ALKERMES PLC-15.91%7 315
ICON PLC4.90%6 551
EXACT SCIENCES CORPORATION-10.93%5 781
IONIS PHARMACEUTICALS INC-3.56%5 774
BIO-TECHNE CORP17.93%5 747
PRA HEALTH SCIENCES INC-4.17%5 642
CHARLES RIVER LABORATORIES INTL. INC-3.65%5 184
GALAPAGOS-0.08%4 949
UNITED THERAPEUTICS CORPORATION-22.91%4 851
HANGZHOU TIGERMED CONSULTING CO LTD--.--%4 503
ABLYNX115.64%4 138
Connections : Vernalis plc
© 2018 People , Fundamentals and Ownership